Lakeside

[Lakeside @CascadeInvestor]

@NightOwlBiotech 2026 multiple even lower if you use EV instead of MC, which I think is quite relevant here

[Lakeside @CascadeInvestor]

@Lord_of_Biotech yes, should eventually be at a higher multiple...makes no sense here

[Lakeside @CascadeInvestor]

@ScorpionFund what's the date of the FDA letter?

[Lakeside @CascadeInvestor]

@Lord_of_Biotech True…forward looking. Either way your point holds water

[Lakeside @CascadeInvestor]

@PersimmonTI I understand your $CRVS point but I’m not sure what you intend on the $SLNO point….do you mean it’s a stretch to discredit the short report in their case or the opposite?

[Lakeside @CascadeInvestor]

Sean, the selling is under a 10b5-1 plan, so the parameters were set up quite a while ago by her and are basically automated. More importantly, these options expire in February 2026 (typically 10-year options), so if she doesn't exercise them...they will expire. In summary, the sales are not alarming in my opinion.

[Lakeside @CascadeInvestor]

@adamfeuerstein @Sports_bios Very sorry to hear that. He was very prolific and generous

[Lakeside @CascadeInvestor]

@BiotechTVHQ @gline This is one of the more coherent explanations of the biggest, less obvious, or less spoken out loud, challenges facing biotech right now

[Lakeside @CascadeInvestor]

@Biohazard3737 @Bandit_Capital @TheBio_Hunter That scenario could happen, you're right. Seeing branded pricing go up in the U.S. so egregiously for the last 25 years handicaps it the other direction for me...but who knows for sure.

[Lakeside @CascadeInvestor]

@Bandit_Capital @Biohazard3737 @TheBio_Hunter Yes, Medicare/Medicaid (where the big fed budget numbers are) and relative drug pricing to ROW (lack of fairness, a big Trump focus)

[Lakeside @CascadeInvestor]

@BiomedicalRX @yaireinhorn Pricing rules the day…

[Lakeside @CascadeInvestor]

@adamfeuerstein When you know, you know...

[Lakeside @CascadeInvestor]

@adamfeuerstein And $URGN as well. Fred Cohen of Monograph was a supposed independent director but his fund got an inside look and bought $15 million. They weren’t even shareholders.

[Lakeside @CascadeInvestor]

@adamfeuerstein Good man...hey we're all wrong at times. Do you feel the same way about CTIC?

[Lakeside @CascadeInvestor]

@ErikOtto2 please take note $URGN CEO...

[Lakeside @CascadeInvestor]

@Biotenic CVR granted via FDA website today...

[Lakeside @CascadeInvestor]

@adamfeuerstein @Biohazard3737 CTIC never forget

[Lakeside @CascadeInvestor]

@Sports_bios This is one of the best outlines of a very productive investment strategy that works.